Panmure Liberum analyst plans to sell his stocks as S&P 500 crosses key threshold

In a report published on November 19, 2026, CNBC said Panmure Liberum research analyst Joachim Klement planned to sell every stock in his personal holdings by the end of European trading that day and move the proceeds into long-term government bonds. His stated trigger was the S&P 500 falling below its 200-day moving average.

Klement told CNBC the plan covered all his stocks, not only U.S. holdings. In a note issued that Thursday, his team recommended that investors “go fully defensive,” saying market momentum had turned bearish in its view. Klement acknowledged that the moving-average signal could be false and that repeatedly selling and buying back stocks could create substantial portfolio turnover. He said he would return to equities if the index rose above the moving average again.

The call came as Anthropic was expected to make its Nasdaq debut. According to the report, the company had priced its initial public offering at $83 a share on Wednesday and was selling about 980 million shares, raising a reported $81.3 billion. Klement’s team argued that Anthropic’s regulatory filings showed revenue growth slowing both relative to compute costs and in absolute terms. That was the analysts’ interpretation of the filings, not an established conclusion about the wider AI market.

Panmure Liberum had warned since May about the risk of a reversal in AI-related capital spending. Its analysis suggested such a reversal could push stock markets down 30% or more. In September, its analysts forecast that an AI bubble would burst in 2027 or 2028 and put the chance of a 2027 collapse at almost 50%. The following month, they set a year-end 2027 S&P 500 target of 5,000 points—35% below the index level at the time. These were forecasts, not outcomes. The S&P 500 closed at 7,323.63 on Wednesday, November 18, according to the report.

For investors who wanted to stay in stocks while reducing exposure to an AI sell-off, Klement said his team’s analysis pointed to U.K. shares as the strongest regional shelter. The team examined returns around the 10 worst days of 2026 for Goldman Sachs’ Broad AI Basket and identified GSK, AstraZeneca, Unilever, Experian, Diageo, Sage, Haleon, RELX, Reckitt Benckiser and Croda among the FTSE 100 shares it considered the best hedges. That historical comparison does not establish how those stocks would perform in a future downturn.

Further reading